Shandong Wit Dyne Health (000915) Fundamentals 2026 — P/E 12.8x, Revenue Analysis | SniperIQ
Shandong Wit Dyne Health (000915) is a CN-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of ¥5.9B, trading at ¥25.21 on the SHZ. This SniperIQ fundamentals page covers Shandong Wit Dyne Health's valuation (P/E 12.8x, P/B 2.0x), profitability (net margin 22.9%), revenue (¥2.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Shandong Wit Dyne Health's market cap?
Shandong Wit Dyne Health (000915) has a market capitalization of approximately ¥5.9B, trading at ¥25.21 on the SHZ. Market cap moves with the live share price.
What is Shandong Wit Dyne Health's P/E ratio?
Shandong Wit Dyne Health's trailing twelve-month P/E ratio is 12.8x, with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Shandong Wit Dyne Health?
Shandong Wit Dyne Health runs a net profit margin of 22.9%, a gross margin of 84.0%, and an operating margin of 51.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Shandong Wit Dyne Health generate?
Shandong Wit Dyne Health reported revenue of ¥2.2B for fiscal year 2025, with net income of ¥535M and earnings per share (EPS) of 2.28. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Shandong Wit Dyne Health pay a dividend?
Shandong Wit Dyne Health offers a trailing dividend yield of about 9.9%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Shandong Wit Dyne Health financially healthy?
Shandong Wit Dyne Health carries a debt-to-equity ratio of 0.00x and a current ratio of 12.06x, with a market beta of -0.04. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Shandong Wit Dyne Health a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Shandong Wit Dyne Health (000915) the key facts are: market cap ¥5.9B, P/E 12.8x, revenue ¥2.2B, 52-week range 23.93-36.7. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Shandong Wit Dyne Health's full fundamentals live
Get Shandong Wit Dyne Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.